Depomed, Inc. Recalls 52 Lots of Diabetes Drug, Glumetza

Reuters -- Drug developer Depomed Inc (DEPO.O) said it will recall 52 lots of its diabetes drug Glumetza due to the presence of traces of a certain chemical in the tablet's 500 mg bottle.
MORE ON THIS TOPIC